1-二乙基氨-2-丙醇 | 4402-32-8

• 物质功能分类: 化学试剂 - 有机试剂 - 脂肪醇
• 分子结构分类: 有机化合物 - 有机氮化合物
• 中文名称: 1-二乙基氨-2-丙醇
• 中文别名: 1-二乙氨基-2-丙醇；1-二乙胺基-2-丙醇；1-二乙基氨基-2-丙醇
• 英文名称: 1-diethylamino-2-propanol
• 英文别名: N,N-diethyl-N-(2-hydroxypropyl)amine；N,N-diethyl-2-hydroxypropylamine；3-(N,N-diethylamino)propan-2-ol；1-Methyl-2-diethylaminoethanol；1-(Diethylamino)-2-propanol；1-diethylaminopropan-2-ol；1-(diethylamino)propan-2-ol
• CAS: 4402-32-8
• 化学式: C₇H₁₇NO
• 分子量: 131.218
• InChiKey: BHUXAQIVYLDUQV-UHFFFAOYSA-N

物化性质

• 熔点：
  13.5 °C(lit.)
• 沸点：
  55-59 °C13 mm Hg(lit.)
• 密度：
  0.889 g/mL at 25 °C(lit.)
• 闪点：
  92 °F
• 稳定性/保质期：
  在常温常压下保持稳定

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  9
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  23.5
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 危险等级：
  3
• 危险品标志：
  Xi
• 安全说明：
  S24/25
• 危险类别码：
  R10,R36/37/38
• WGK Germany：
  3
• 海关编码：
  2922199090
• 包装等级：
  III
• 危险类别：
  3
• 危险品运输编号：
  UN 1987 3/PG 3
• 危险性防范说明：
  P501,P240,P210,P233,P243,P241,P242,P264,P280,P370+P378,P303+P361+P353,P301+P330+P331,P363,P304+P340+P310,P305+P351+P338+P310,P403+P235,P405
• 危险性描述：
  H225,H314
• 储存条件：
  避光、存于通风干燥处并密封保存。

SDS

Name:	1-Diethylamino-2-Propanol 97% Material Safety Data Sheet
Synonym:	None known
CAS:	4402-32-8

Section 1 - Chemical Product MSDS Name:1-Diethylamino-2-Propanol 97% Material Safety Data Sheet
Synonym:None known

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
4402-32-8	1-Diethylamino-2-Propanol	97	224-537-7

Hazard Symbols: XI
Risk Phrases: 10 36/37/38

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Flammable. Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation. May cause chemical conjunctivitis and corneal damage.
Skin:
Causes skin irritation. May cause irritation and dermatitis. May cause cyanosis of the extremities.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and diarrhea. The toxicological properties of this substance have not been fully investigated. Ingestion of large amounts may cause CNS depression.
Inhalation:
Causes respiratory tract irritation. The toxicological properties of this substance have not been fully investigated. Aspiration may lead to pulmonary edema. Vapors may cause dizziness or suffocation. Can produce delayed pulmonary edema. May cause burning sensation in the chest.
Chronic:
Effects may be delayed.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid. Do NOT use mouth-to-mouth resuscitation.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. Vapors may form an explosive mixture with air.
Vapors can travel to a source of ignition and flash back. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Will burn if involved in a fire. Use water spray to keep fire-exposed containers cool. Water may be ineffective. Material is lighter than water and a fire may be spread by the use of water. Containers may explode in the heat of a fire.
Flammable liquid and vapor. Vapors may be heavier than air. They can spread along the ground and collect in low or confined areas.
Extinguishing Media:
For small fires, use dry chemical, carbon dioxide, water spray or alcohol-resistant foam. For large fires, use water spray, fog, or alcohol-resistant foam. Use water spray to cool fire-exposed containers. Water may be ineffective. Do NOT use straight streams of water.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container. Avoid runoff into storm sewers and ditches which lead to waterways. Clean up spills immediately, observing precautions in the Protective Equipment section. Remove all sources of ignition. Use a spark-proof tool. Provide ventilation. A vapor suppressing foam may be used to reduce vapors.

---

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Use with adequate ventilation.
Ground and bond containers when transferring material. Use spark-proof tools and explosion proof equipment. Avoid contact with eyes, skin, and clothing. Empty containers retain product residue, (liquid and/or vapor), and can be dangerous. Keep container tightly closed. Keep away from heat, sparks and flame. Avoid ingestion and inhalation. Wash clothing before reuse. Do not pressurize, cut, weld, braze, solder, drill, grind, or expose empty containers to heat, sparks or open flames.
Storage:
Keep away from heat, sparks, and flame. Keep away from sources of ignition. Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Flammables-area.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate general or local explosion-proof ventilation to keep airborne levels to acceptable levels.
Exposure Limits CAS# 4402-32-8: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Liquid
Color: clear slightly yellow
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 55.0 - 59.0 deg C @ 13.00mmHg
Freezing/Melting Point: 13.5 deg C
Autoignition Temperature: Not available.
Flash Point: 33 deg C ( 91.40 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density: .8890g/cm3
Molecular Formula: C7H17NO
Molecular Weight: 131.22

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable at room temperature in closed containers under normal storage and handling conditions.
Conditions to Avoid:
Incompatible materials, ignition sources, excess heat, strong oxidants.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, irritating and toxic fumes and gases, carbon dioxide, nitrogen.
Hazardous Polymerization: Has not been reported.

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 4402-32-8 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
1-Diethylamino-2-Propanol - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: ALCOHOLS, N.O.S.*
Hazard Class: 3
UN Number: 1987
Packing Group: III
IMO
Shipping Name: ALCOHOLS, N.O.S.
Hazard Class: 3.3
UN Number: 1987
Packing Group: III
RID/ADR
Shipping Name: ALCOHOLS, FLAMMABLE, N.O.S.
Hazard Class: 3
UN Number: 1987
Packing group: III

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 10 Flammable.
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 7 Keep container tightly closed.
S 9 Keep container in a well-ventilated place.
S 16 Keep away from sources of ignition - No
smoking.
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 28A After contact with skin, wash immediately with
plenty of water.
S 33 Take precautionary measures against static
discharges.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 4402-32-8: No information available.
Canada
CAS# 4402-32-8 is listed on Canada's NDSL List.
CAS# 4402-32-8 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 4402-32-8 is listed on the TSCA inventory.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  1-二乙基氨-2-丙醇 在 二溴亚砜 作用下， 生成 diethyl-(2-bromo-propyl)-amine
  参考文献：
  名称：

  Charpentier et al., Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences, 1951, vol. 232, p. 2232

  摘要：

  DOI：
• 作为产物：
  描述：

  二乙胺基丙酮 在 sodium amalgam 、 乙醇 作用下， 生成 1-二乙基氨-2-丙醇
  参考文献：
  名称：

  Takahashi; Senda, Yakugaku Zasshi/Journal of the Pharmaceutical Society of Japan, 1949, vol. 69, p. 412

  摘要：

  DOI：
• 作为试剂：
  描述：

  perfluorophenyl 2-((tert-butoxycarbonyl)amino)acetate 、 Ts-Glu(OBzl)-OBzl 在 1-二乙基氨-2-丙醇 作用下， 以 氯仿 为溶剂， 反应 2.0h， 以90%的产率得到N-Boc-甘氨酰-L-谷氨酸二苄基酯
  参考文献：
  名称：

  One-Pot Liquid-Phase Synthesis of DSIP and 5-Phe-DSIP Using Fluoren-9-yl-methoxycarbonyl-Protected Amino Acid Pentafluorophenyl Esters

  摘要：

  Fmoc 保护的氨基酸五氟苯酯用于一锅液相合成 Delta 睡眠诱导肽 (DSIP) 和 5-Phe-DSIP。该方法的优点是操作简单、性能快、产量高、纯度高，这可能代表了一种改进的多肽合成方法。

  DOI：

  10.1055/s-1990-27032

文献信息

• Synthesis and Antitumor Activity of 3-Methyl-4-oxo-3,4-dihydroimidazo [5,1-d][1,2,3,5]tetrazine-8-carboxylates and -carboxamides
  作者：Dan Liu、Jian-Guo Yang、Jie Cheng、Lin-Xiang Zhao

  DOI：10.3390/molecules15129427

  日期：——

  Seventeen novel 3-methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxylate and -carboxamide derivatives were synthesized and evaluated for their growth inhibition in seven human solid tumor and a human leukemia HL-60 cell lines. Compound IVa showed more activity than the other compounds and the positive control temozolomide. In the presence of 40 mg/mL of IVa, the survival rate of all tested tumor cells was less than 10%. Esters displayed more potent antitumour activity than amides and temozolomide against HL-60 cells. These compounds also exhibited considerably enhanced water-solubility.

  合成了17种新颖的3-甲基-4-氧代-3,4-二氢咪唑并[5,1-d][1,2,3,5]四氮杂-8-甲酸酯和甲酰胺衍生物，并评估了它们对7种人实体瘤和一种人白血病HL-60细胞系的生长抑制作用。化合物IVa显示出比其他化合物和阳性对照替莫唑胺更高的活性。在IVa浓度为40 mg/mL时，所有检测的肿瘤细胞存活率均低于10%。酯类化合物对HL-60细胞的抗肿瘤活性比酰胺类和替莫唑胺更强。这些化合物还表现出显著增强的水溶性。
• [EN] TARGETED DELIVERY TO BETA CELLS<br/>[FR] ADMINISTRATION CIBLÉE À DES CELLULES BÊTA
  申请人：CHOUDHARY AMIT

  公开号：WO2018195486A1

  公开（公告）日：2018-10-25

  The disclosure includes zinc prodrugs for targeted delivery of therapeutic, diagnostic or imaging agents to β-cells and methods of use therefor. The disclosure also includes targeted delivery of small molecules to β-cells that stabilize and activate CRISPR effector proteins comprising at least one destabilization domain, to enable CRISPR-based genome editing and transcriptional activation or repression in β-cells.

  本公开内容包括用于将治疗性、诊断性或成像剂靶向递送至β细胞的锌前药及其使用方法。本公开内容还涉及将小分子靶向递送至β细胞，这些小分子能够稳定并激活至少含有一个不稳定域的CRISPR效应蛋白，从而在β细胞中实现基于CRISPR的基因编辑和转录激活或抑制。
• Monosaccharide derivatives as anti-inflammatory agents
  申请人：Ranbaxy Laboratories Limited

  公开号：EP1953170A1

  公开（公告）日：2008-08-06

  The present invention relates to monosaccharide derivatives as anti-inflammatory agents. The compounds disclosed herein can be useful for inhibition and prevention of inflammation and associated pathologies including inflammatory, cancer, cardiovascular and autoimmune diseases such as bronchial asthma, rheumatoid arthritis, type-I diabetes, multiple sclerosis, allograft rejection, psoriasis, inflammatory bowel disease, ulcerative colitis, acne, atherosclerosis, pruritis or allergic rhinitis. Pharmacological compositions containing compounds disclosed herein and the methods of treating diseases such as bronchial asthma, rheumatoid arthritis, type-I diabetes, multiple sclerosis, cancer, cardiovascular diseases, allograft rejection, psoriasis, inflammatory bowel disease, ulcerative colitis, acne, atherosclerosis, pruritis or allergic rhinitis and other inflammatory and/or autoimmune disorders, using the compounds are also provided.

  本发明涉及单糖衍生物作为抗炎药剂。本文披露的化合物可用于抑制和预防炎症及相关病理，包括炎症性、癌症、心血管和自身免疫疾病，如支气管哮喘、类风湿关节炎、I型糖尿病、多发性硬化症、移植排斥、牛皮癣、炎症性肠病、溃疡性结肠炎、痤疮、动脉粥样硬化、瘙痒或过敏性鼻炎。还提供了含有本文披露的化合物的药理组合物和治疗支气管哮喘、类风湿关节炎、I型糖尿病、多发性硬化症、癌症、心血管疾病、移植排斥、牛皮癣、炎症性肠病、溃疡性结肠炎、痤疮、动脉粥样硬化、瘙痒或过敏性鼻炎等疾病的方法，以及使用这些化合物治疗其他炎症性和/或自身免疫性疾病的方法。
• Recherches sur la formation et la transformation des esters LVI. Action de l'acide sulfurique sur les aminoalcools
  作者：Emile Cherbuliez、C. Chapalay、Sl. ?olak-Anti?、J. Marszalek、L. Vallet、J. Rabinowitz

  DOI：10.1002/hlca.19640470754

  日期：——

  By heating an equimolecular mixture of an amino alcohol and H2SO4 during an appropriated time (half an hour to some hours) at 180–200°C under reduced pressure, the corresponding aminoalkyl sulfuric monoester is obtained in very good yield.

  通过在适当的时间（半小时至数小时）内在减压下于180-200℃下加热氨基醇和H 2 SO 4的等分子混合物，可以非常好的收率获得相应的氨基烷基硫酸单酯。
• [EN] NOVEL PYRIDINE DERIVATIVES<br/>[FR] NOUVEAUX DÉRIVÉS DE PYRIDINE
  申请人：HOFFMANN LA ROCHE

  公开号：WO2014154612A1

  公开（公告）日：2014-10-02

  The invention relates to a compound of formula (I); wherein A and R1 to R4 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.

  这项发明涉及一种化合物，其化学式为（I）；其中A和R1至R4的定义如描述和权利要求中所述。化合物的化学式（I）可用作药物。

表征谱图